Literature DB >> 401733

Binding of prolactin by fetal rhesus cell membrane fractions.

J B Josimovich, K Merisko, L Boccella, H Tobon.   

Abstract

Interest in possible physiologic roles of prolactin in the developing fetus led to the present study of affinity of human prolactin to fetal rhesus cell membrane fractions. The fractions were prepared by ultracentrifugation and their composition confirmed by electron microscopy. The cell membrane preparations were derived from the fetal placenta, liver, lung, myocardium and brain. Kinetic studies showed apparent binding affinity constants for 125I-labeled human prolactin (hPRL) of the order of 10(9)M-1 and capacities of from 3 ng to over a microgram per organ in late pregnancy for all of these tissues except brain. The calculated binding capacities, although probably underestimated, were found sufficiently high to insure that a portion of maternal and fetal prolactin exists in bound form to fetal tissues, consistent with possible roles in the regulation of fetal tissue cellular function, and provided they have access to circulating PRL.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 401733     DOI: 10.1210/endo-100-2-557

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  4 in total

1.  Ontogenesis of prolactin receptors in the human fetus in early gestation. Implications for tissue differentiation and development.

Authors:  M Freemark; P Driscoll; R Maaskant; A Petryk; P A Kelly
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

2.  Plasma prolactin and clinical outcome in preterm infants.

Authors:  A Lucas; B A Baker; T J Cole
Journal:  Arch Dis Child       Date:  1990-09       Impact factor: 3.791

3.  Purification of a distinct placental lactogen receptor, a new member of the growth hormone/prolactin receptor family.

Authors:  M Freemark; M Comer
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

Review 4.  Lung surfactant.

Authors:  S A Rooney
Journal:  Environ Health Perspect       Date:  1984-04       Impact factor: 9.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.